Brian D Johnston (Brian Johnston)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Venues

Microbiology resource announcements

Journal of clinical microbiology

Antimicrobial agents and chemotherapy

Virulence

University of Minnesota System

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Minnesota System Dec 01 2004

United States

Sr. Scientist :: Medicine

Publications

Khulud Alotaibi, Ashraf A Khan, Bernard Marasa, Saeed A Khan, James R Johnson, Brian D Johnston, Kidon Sung, Mohamed Nawaz
Draft Genome Sequences of Sixteen Fluoroquinolone-Resistant Extraintestinal Escherichia coli Isolates from Human Patients. Microbiology resource announcements 11 (4) (2022)
Irene Merino, Stephen B Porter, Brian D Johnston, Connie Clabots, Paul Thuras, Patricia Ruiz-Garbajosa, Rafael Cantón, James R Johnson
Molecularly defined extraintestinal pathogenic Escherichia coli status predicts virulence in a murine sepsis model better than does virotype, individual virulence genes, or clonal subset among E. coli ST131 isolates. Virulence 11 (1) (2021)
Brian D Johnston, Paul Thuras, Stephen B Porter, Melissa Anacker, Brittany VonBank, Paula Snippes Vagnone, Medora Witwer, Mariana Castanheira, James R Johnson
Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region. The Journal of antimicrobial chemotherapy 76 (8) (2021)
Anna Maria Malberg Tetzschner, James R Johnson, Brian D Johnston, Ole Lund, Flemming Scheutz
In Silico Genotyping of Escherichia coli Isolates for Extraintestinal Virulence Genes by Use of Whole-Genome Sequencing Data. Journal of clinical microbiology 58 (10) (2020)
Brian D Johnston, Paul Thuras, Stephen B Porter, Melissa Anacker, Brittany VonBank, Paula Snippes Vagnone, Medora Witwer, Mariana Castanheira, James R Johnson
Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region. Antimicrobial agents and chemotherapy 64 (10) (2020)

Brian D Johnston.css-eqlu8i{font-size:small;padding-left:4px;} (Brian Johnston)

Publication Activity (10 Years)

Top Topics

Top Venues

Brian D Johnston (Brian Johnston)